Current strategies for targeted therapy of liver fibrosis
Liver fibrosis (LF) is an unfavorable event in the natural course of chronic liver diseases (CLD), therefore, early implementation and widespread use of antifibrotic therapy methods is a pressing issue in hepatology. The aim of the review was to describe current approaches to targeted therapy of LF....
Saved in:
| Main Author: | D. V. Garbuzenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2022-10-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/4918 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01) -
Modern concepts on pathogenetic mechanisms of liver fibrosis
by: N. A. Efremova, et al.
Published: (2023-04-01) -
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01) -
Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective
by: Xiangchang Zeng, et al.
Published: (2025-05-01) -
Pathogenesis and current status of the treatment of lung cancer associated with idiopathic pulmonary fibrosis
by: Yuanyuan Zhang, et al.
Published: (2025-07-01)